This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05964413
Brief Title: Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

First Submitted : June 29, 2023
First Submitted that Met QC Criteria : July 24, 2023
First Posted : July 27, 2023

Last Update Submitted that Met QC Criteria : March 1, 2024
Last Update Posted : March 4, 2024